Stock SENSI SENSIDOSE AB
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Sensidose AB

Equities

SENSI

SE0017232671

LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In

Latest news about Sensidose AB

Navamedic ASA (OB:NAVA) completed the acquisition of Sensidose AB. CI
EQL Pharma AB cancelled the acquisition of all the remaining stake in Sensidose AB. CI
Sensidose AB Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Sweden’s EQL Pharma Increases Bid for Sensidose MT
Navamedic Raises Takeover Offer for Sensidose, Agrees to Buy 57% Stake MT
EQL Pharma Launches SEK91 Million Takeover Bid for Sensidose MT
EQL Pharma AB made an offer to acquire all the remaining stake in to acquire Sensidose AB for SEK 91.7 million. CI
Navamedic ASA (OB:NAVA) made an offer to acquire Sensidose AB for SEK 96 million. CI
Sensidose AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022 CI
Sensidose AB Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Certain Shares of Sensidose AB are subject to a Lock-Up Agreement Ending on 9-FEB-2023. CI
Sensidose AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Sensidose Starts Trading on Sweden's Spotlight Stock Market MT
Sensidose AB has completed an IPO in the amount of SEK 24.2355 million. CI
Sensidose AB has filed an IPO in the amount of SEK 24.2355 million. CI

Chart Sensidose AB

Chart Sensidose AB
More charts

Company Profile

Sector
-
More about the company
  1. Stock Market
  2. Equities
  3. SENSI Stock
  4. News Sensidose AB
  5. Sensidose Starts Trading on Sweden's Spotlight Stock Market